HomeAI · summaries
Storia in 16 fonti
Cepi funds three prospective vaccines targeting the epidemic-causing Ebola virus
Cepi funds three investigational vaccines for Bundibugyo ebolavirus, advancing urgent health solutions amidst a major outbreak.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus
Coalition for Epidemic Preparedness Innovationsfunding builds on Moderna's prior filovirus research and supports preclinical development and Phase 1 clinical evaluation CAMBRIDGE,…
- ·
independent.co.uk
Moderna receives $50 million to develop Ebola vaccine as number of cases surge
This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has seen over 900 suspected cases and more than 220…
- ·
aftenposten.no
Vaksinekoalisjon finansierer rask utvikling av tre ebolavaksine-kandidater
Vaksinealliansen CEPI har besluttet å hurtigfinansiere tre ulike vaksinekandidater mot varianten av ebolaviruset som nå herjer i Kongo og Uganda.
- ·
it.euronews.com
Autorità sanitaria accelera tre vaccini anti Ebola in piena diffusione
L’ente globale per la salute CEPI sta accelerando lo sviluppo di tre vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola, mentre il focolaio in Africa centrale continua a…
- ·
euronews.com
Health body fast-tracks three Ebola vaccines as virus continues spread
Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.
- ·
Autorità sanitaria accelera tre vaccini anti Ebola
L’ente globale per la salute CEPI sta accelerando lo sviluppo di vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola. Il focolaio in Africa centrale continua a propagarsi
- ·
qz.com
Moderna partners with CEPI on Bundibugyo Ebola vaccine
CEPI is committing up to $50 million to support Moderna's vaccine candidate for the strain with no approved shot
- ·
g4media.ro
Trei noi vaccinuri experimentale pentru virusul Ebola vor fi finanțate de Coaliția pentru Inovații în domeniul Pregătirii pentru Epidemii
Coaliția pentru Inovații în domeniul Pregătirii pentru Epidemii (CEPI) va „accelera de urgență” dezvoltarea a trei vaccinuri experimentale împotriva virusului Bundibugyo,…
- ·
koreatimes.co.kr
Moderna and other groups get $60 million to develop Ebola vaccine - The Korea Times
Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebo...
- ·
arabnews.com
Moderna and other groups get $60m to develop Ebola vaccine
BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…
- ·
arstechnica.com
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.
- ·
thejakartapost.com
Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post
The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.
- ·
economictimes.indiatimes.com
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding
Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fresh funding to combat a spreading outbreak…
- ·
nation.africa
Scientists target human trials for new Ebola vaccine 'within months'
This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.
- ·
businessday.ng
Race for Ebola vaccine gets $60m boost - Businessday NG
Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots...
- ·
newsbytesapp.com
Serum Institute to manufacture Ebola vaccine developed by Oxford University
The Serum Institute of India will produce trial doses of Oxford's experimental Ebola vaccine, supported by $8.6 million in CEPI funding to combat Bundibugyo ebolavirus outbreaks.
- ·
3 Ebola vaccines being developed amid outbreak in Africa
Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.
- ·
thehindubusinessline.com
Cepi funds three prospective vaccines targeting the epidemic-causing Ebola virus
Cepi funds three investigational vaccines for Bundibugyo ebolavirus, advancing urgent health solutions amidst a major outbreak.